Evidence map›Paper›PMID 39461863›Full record

ArticleBMJ open2024

Patient delay, diagnosis delay, and treatment outcomes among migrant patients with tuberculosis in Shanghai, China, 2018-2020: a mixed-methods study.

Yufei Jia, Weixi Jiang, Xiao Xiao, Zhexun Lou, Shenglan Tang, Jing Chen, Qian Long

Abstract read
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Patients, antibiotics andJAC-antimicrobial resistance · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yufei JiaGlobal Health Research Center, Duke Kunshan University, Kunshan, Jiangsu, China.ORCID 0009-0000-5456-2525
Weixi JiangSchool of Public Health, Fudan University, Shanghai, China.
Xiao XiaoShanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Zhexun LouGlobal Health Research Center, Duke Kunshan University, Kunshan, Jiangsu, China.
Shenglan TangDuke Global Health Institute, Duke University, Durham, North Carolina, USA.
Jing ChenShanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Qian LongGlobal Health Research Center, Duke Kunshan University, Kunshan, Jiangsu, China qian.long@dukekunshan.edu.cn.ORCID 0000-0003-1444-6815

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to examine patient delay, diagnosis delay and treatment performance among patients with tuberculosis (TB) in Shanghai, China in 2018-2020 focusing on disparities between migrant and local patients with TB.

designMixed-method study. SETTING AND

participantsQuantitative data were collected from the TB information management system in Shanghai; 17 533 bacteriologically confirmed and clinically diagnosed patients with pulmonary TB registered in 2018-2020 were included. Qualitative interviews were conducted with TB administrators (n=3) and community healthcare providers (two groups, n=10 in total) from Shanghai.

main outcome measuresPatient delay, diagnosis delay and treatment completion were examined by resident type using descriptive analysis and logistic regressions. Qualitative interviews were conducted to understand factors associated with the disparities.

resultsFrom 2018 to 2020, migrant patients with TB accounted for 44.40% of total cases. There was no significant difference in patient delay between migrant and local patients (18.47 days on average). 22.12% of migrants and 16.52% of locals experienced diagnosis delays exceeding 14 days, respectively. After adjusting for all variables, migrant patients (OR 1.30, 95% CI 1.18 to 1.44) and initial care seeking at general hospitals (OR 3.76, 95% CI 3.45 to 4.09) were associated with a higher probability of diagnosis delay. 93.9% of migrant patients and 89.4% of the local patients had a successful TB treatment without statistically significant difference after adjusting for all variables. Qualitative interviews revealed a standard approach to managing patients with TB in Shanghai no matter their resident type. Young migrant patients who were able to maintain their jobs in Shanghai often had better treatment adherence. Despite patients' COVID-19 fear and limited care access in 2020, TB treatment minimally affected for both due to community-based case management.

conclusionsMigrant patients were more likely to experience diagnosis delay. It should improve awareness and knowledge of TB among healthcare professionals at general hospitals to mitigate the risk of diagnosis delay.

Indexed as

Delayed DiagnosisTransients and MigrantsTuberculosis, PulmonaryAdolescentAdultAgedChinaFemaleHumansMaleMiddle AgedQualitative ResearchTime-to-TreatmentTreatment OutcomeYoung AdultCOVID-19Health policyPatientsPrimary Health CareTuberculosis

Identifiers

PMID39461863
PMCPMC11529733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.